Symphony Financial Ltd. Co. reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 70.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,710 shares of the semiconductor company’s stock after selling 4,159 shares during the quarter. Symphony Financial Ltd. Co.’s holdings in Synopsys were worth $825,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in SNPS. Y Intercept Hong Kong Ltd purchased a new stake in Synopsys in the 3rd quarter valued at about $7,544,000. Mn Services Vermogensbeheer B.V. grew its holdings in Synopsys by 22.0% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 70,528 shares of the semiconductor company’s stock valued at $34,798,000 after purchasing an additional 12,728 shares during the period. Baillie Gifford & Co. grew its holdings in Synopsys by 20.8% in the third quarter. Baillie Gifford & Co. now owns 26,620 shares of the semiconductor company’s stock valued at $13,134,000 after purchasing an additional 4,582 shares during the period. Resona Asset Management Co. Ltd. increased its position in Synopsys by 16.3% during the third quarter. Resona Asset Management Co. Ltd. now owns 62,385 shares of the semiconductor company’s stock worth $30,655,000 after purchasing an additional 8,758 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp raised its stake in Synopsys by 16.2% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 111,449 shares of the semiconductor company’s stock worth $54,988,000 after purchasing an additional 15,559 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $501.39 on Friday. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The business’s 50-day moving average price is $466.97 and its two-hundred day moving average price is $504.27. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The company has a market capitalization of $95.93 billion, a P/E ratio of 62.75, a price-to-earnings-growth ratio of 4.24 and a beta of 1.12.
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on SNPS shares. BNP Paribas Exane assumed coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Morgan Stanley upped their price target on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and decreased their target price for the stock from $605.00 to $560.00 in a report on Tuesday, December 9th. KeyCorp increased their price objective on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, JPMorgan Chase & Co. raised their price objective on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus target price of $553.57.
Get Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
